Form 4: USANA Health Sciences Director Ding Xia Reports Acquisition of Restricted Stock Units

Director Ding Xia reports acquisition of 2,697 restricted stock units in USANA Health Sciences, vesting in installments through May 2025.

Summary

• On May 2, 2024, Ding Xia, a director of USANA Health Sciences Inc., acquired 2,697 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of USNA common stock.
• The RSUs vest in four equal installments: August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.
• Following the transaction, Ding Xia directly owns 2,697 derivative securities.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of stock unit acquisition. The vesting schedule indicates a long-term perspective from the director.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock units suggests a long-term commitment by the director to the company's success.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Stakeholder Impact

• The acquisition of restricted stock units by a director can positively influence shareholder confidence.

Key Dates